After USA and Britain, European Medicines Agency has approved the the conditional use of BioNTech Pfizer developed vaccine shot across European Union. In a meeting held on Monday, the European Union drug regulators agreed that the shot can be used in people over the age of 16 with exceptions. But the stipulation is added that the pharmaceutical company will have to provide the follow-up data of their vaccine next year. The European countries are hoping to start their vaccination process from December 27.